Holen Sie sich die Stockscreener-App
1.46
8.15%
0.11
Handel nachbörslich:
1.49
0.03
+2.05%
Schlusskurs vom Vortag:
$1.35
Offen:
$1.36
24-Stunden-Volumen:
544.65K
Relative Volume:
0.64
Marktkapitalisierung:
$94.30M
Einnahmen:
$212.69M
Nettoeinkommen (Verlust:
$-59.00M
KGV:
-1.5637
EPS:
-0.9337
Netto-Cashflow:
$-29.49M
1W Leistung:
+2.10%
1M Leistung:
-21.51%
6M Leistung:
-79.78%
1J Leistung:
-81.61%
1-Tages-Spanne:
$1.34
$1.46
1-Wochen-Bereich:
$1.34
$1.67
52-Wochen-Spanne:
$1.31
$8.87
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Firmenname
Treace Medical Concepts Inc
Sektor
Branche
Telefon
(904) 373-5940
Adresse
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
1.46 | 87.20M | 212.69M | -59.00M | -29.49M | -0.9337 |
|
ABT
Abbott Laboratories
|
108.03 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-11-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-02-04 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-12-31 | Eingeleitet | Lake Street | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-05-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-08 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-08 | Herabstufung | Truist | Buy → Hold |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2023-05-01 | Eingeleitet | Truist | Buy |
| 2023-04-11 | Eingeleitet | Stephens | Equal-Weight |
| 2022-05-12 | Eingeleitet | BTIG Research | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-05-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-18 | Eingeleitet | Stifel | Buy |
Alle ansehen
Treace Medical Concepts Inc Aktie (TMCI) Neueste Nachrichten
Resistance Check: Is Treace Medical Concepts Inc gaining market shareMarket Trend Summary & Technical Buy Zone Confirmations - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Reach Out - ACCESS Newswire
Market Catalysts: Why is Treace Medical Concepts Inc stock going up2025 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Treace Medical Concepts Hits New 52-Week Low at $1.58 - Markets Mojo
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2025 Earnings Call Transcript - Insider Monkey
Treace Medical Concepts (NASDAQ:TMCI) Given New $7.00 Price Target at Lake Street Capital - Defense World
Treace Medical Concepts (NASDAQ:TMCI) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
TMCI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Treace Medical Earnings Call Balances Progress and Pressure - TipRanks
Lake Street Capital Issues Pessimistic Forecast for Treace Medical Concepts (NASDAQ:TMCI) Stock Price - MarketBeat
Treace Medical Concepts Q4 Earnings Call Highlights - Defense World
Truist Securities Adjusts Treace Medical Concepts PT to $2 From $3, Maintains Hold Rating - marketscreener.com
Treace Medical net loss hits USD 9.4M in Q4 2025 - Medical Buyer
Treace Medical Concepts, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Treace Medical Concepts Q4 Loss Narrowing Challenges Persistent Bearish Narratives On Profitability - Sahm
Treace Medical Concepts, Inc. (TMCI): Investor Outlook Reveals Potential 100% Upside - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Connect - ACCESS Newswire
Treace Medical Concepts (NASDAQ:TMCI) Issues Quarterly Earnings Results - MarketBeat
Treace Medical Concepts Inc (TMCI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Is Treace Medical Concepts Inc gaining market shareEarnings Growth Report & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Earnings call transcript: Treace Medical Concepts Q4 2025 reports revenue decline, stock edges up - Investing.com Canada
Treace Medical Concepts Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Treace Medical Concepts earnings missed, revenue topped estimates By Investing.com - Investing.com Canada
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Full Year 2026 - marketscreener.com
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
TREACE MEDICAL CONCEPTS, INC. SEC 10-K Report - TradingView
Treace Medical Concepts: Q4 Earnings Snapshot - marketscreener.com
Treace Medical Concepts (NASDAQ: TMCI) posts 2025 loss and guides flat-to-down 2026 sales - Stock Titan
Treace Medical Concepts Q4 Earnings Summary & Key Takeaways - Benzinga
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results - Bluefield Daily Telegraph
Treace Medical Concepts Q4 2025 Earnings Call Transcript - MarketBeat
Treace Medical Concepts: Fourth Quarter Financial Results Overview - Bitget
Treace Medical Concepts's Earnings: A Preview - Benzinga
Treace Medical Concepts Inc (TMCI) Q4 2025 Earnings Report Previ - GuruFocus
Treace Medical Concepts Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Will Treace Medical Concepts Inc. outperform tech stocksJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - mfd.ru
Treace Medical Concepts Unveils Updates to Lapiplasty 3D Bunion Correction System at 2026 ACFAS Conference - geneonline.com
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference - The Globe and Mail
New bunion surgery tools show patients back walking in days - Stock Titan
TMCITreace Medical Concepts, Inc. Latest Stock News & Market Updates - Stock Titan
Treace Medical Concepts (NASDAQ:TMCI) Upgraded to “Hold” at Wall Street Zen - Defense World
Treace Medical Concepts (NASDAQ:TMCI) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Will Treace Medical Concepts Inc. stock attract more institutional investors2025 Market Outlook & Verified High Yield Trade Plans - mfd.ru
Treace Medical Concepts, Inc. (TMCI) Investor Outlook: Exploring a 118.75% Potential Upside Amidst Healthcare Innovation - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts (TMCI) to Release Quarterly Earnings on Thursday - MarketBeat
What Catalysts Are Shifting The Narrative For Treace Medical Concepts (TMCI)? - Yahoo Finance
Retail Trends: How much upside does Treace Medical Concepts Inc have2025 Major Catalysts & Weekly Top Gainers Trade List - baoquankhu1.vn
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Rating of "Reduce" by Brokerages - MarketBeat
Finanzdaten der Treace Medical Concepts Inc-Aktie (TMCI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.66%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):